These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8289082)

  • 1. Antibodies to skeletal muscle in myasthenia gravis. Part 2. Prevalence in non-thymoma patients.
    Kuks JB; Limburg PC; Horst G; Oosterhuis HJ
    J Neurol Sci; 1993 Dec; 120(1):78-81. PubMed ID: 8289082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to skeletal muscle in myasthenia gravis. Part 1. Diagnostic value for the detection of thymoma.
    Kuks JB; Limburg PC; Horst G; Dijksterhuis J; Oosterhuis HJ
    J Neurol Sci; 1993 Nov; 119(2):183-8. PubMed ID: 8277333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
    Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
    Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart muscle antibodies in myasthenia gravis.
    Mygland A; Aarli JA; Hofstad H; Gilhus NE
    Autoimmunity; 1991; 10(4):263-7. PubMed ID: 1772962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of antibodies to citric acid extract of skeletal muscle (CAE-ab) in the sera of patients with myasthenia gravis using indirect hemagglutination].
    Ma W
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):143-5, 189. PubMed ID: 2390884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
    Romi F; Skeie GO; Aarli JA; Gilhus NE
    Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antititin antibody in early- and late-onset myasthenia gravis.
    Szczudlik P; Szyluk B; Lipowska M; Ryniewicz B; Kubiszewska J; Dutkiewicz M; Gilhus NE; Kostera-Pruszczyk A
    Acta Neurol Scand; 2014 Oct; 130(4):229-33. PubMed ID: 24947881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myasthenia gravis: difference between thymoma-associated antibodies and cross-striational skeletal muscle antibodies.
    Gilhus NE; Aarli JA; Matre R
    Neurology; 1984 Feb; 34(2):246-9. PubMed ID: 6363971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnosis of thymoma in myasthenia gravis.
    Aarli JA
    Ital J Neurol Sci; 1983 Dec; 4(4):393-7. PubMed ID: 6370907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis muscle antibodies examined by ELISA: IgG and IgM antibodies characterize different patient subgroups.
    Hofstad H; Ulvestad E; Gilhus NE; Matre R; Aarli JA
    Acta Neurol Scand; 1992 Apr; 85(4):233-8. PubMed ID: 1585794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An enzyme-linked immunosorbent assay for antistriational antibodies associated with myasthenia gravis and thymoma: comparison with indirect immunofluorescence.
    Carrano JA; Swanson NR; Dawkins RL
    J Immunol Methods; 1983 May; 59(3):301-14. PubMed ID: 6343491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients.
    Limburg PC; The TH; Hummel-Tappel E; Oosterhuis HJ
    J Neurol Sci; 1983 Mar; 58(3):357-70. PubMed ID: 6842264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.
    Chen XJ; Qiao J; Xiao BG; Lu CZ
    J Neurol; 2004 Aug; 251(8):1006-11. PubMed ID: 15316806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?
    Choi Decroos E; Hobson-Webb LD; Juel VC; Massey JM; Sanders DB
    Muscle Nerve; 2014 Jan; 49(1):30-4. PubMed ID: 23625360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An enzyme-linked immunosorbent assay for antibodies against acid soluble skeletal muscle antigen in myasthenia gravis.
    Annamma M; Sarada C; Radhakrishnan VV
    Acta Neurol Scand; 1999 Sep; 100(3):175-7. PubMed ID: 10478581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-linked immunosorbent assay for detection of antibodies to extractable muscle antigens in myasthenia gravis.
    Viana VS; Bueno C; Marchiori PE; Oliveira RM; Assis JL; Scaff M; Cossermelli W
    Acta Neurol Scand; 1986 Jun; 73(6):599-601. PubMed ID: 3751500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
    Mygland A; Aarli JA; Matre R; Gilhus NE
    J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HL-A antigens, autoantibody production, and associated diseases in thymoma patients, with and without myasthenia gravis.
    Oosterhuis HJ; Feltkamp TE; van Rossum AL; van den Berg-Loonen PM; Nijenhuis LE
    Ann N Y Acad Sci; 1976; 274():468-74. PubMed ID: 1085589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG subclass distribution of myasthenia gravis thymoma-associated antiskeletal muscle antibodies.
    Smith CI; Aarli JA; Hammarström L; Persson MA
    Neurology; 1984 Aug; 34(8):1094-6. PubMed ID: 6540388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal muscle antibodies in patients with a thymic tumour but without myasthenia gravis.
    Gilhus NE; Aarli JA; Janzen RW; Otto HF; Fasske E; Matre R
    J Neuroimmunol; 1985 May; 8(2-3):69-78. PubMed ID: 3998123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.